mRNA vaccines can enhance immunotherapy efficacy by activating the immune system, improving outcomes in hard-to-treat tumors. mRNA COVID-19 vaccines enhance immune responses, improving cancer ...
Infection Avitar Biosciences presents new 3CLpro inhibitors to treat SARS-CoV-2 infection Feb. 29, 2024 ...
Investigators from Mass General Brigham have found that a method originally designed for cancer detection can also identify and monitor even tiny amounts of SARS-CoV-2 intact viral particles in blood ...
BETHESDA, Md. - Researchers at the National Institutes of Health say they have identified a potential new antiviral drug that could help treat COVID-19. The drug, TEMPOL, is a promising oral antiviral ...
Patients with COVID-19 had lower viral loads if treated with metformin, according to new University of Minnesota research that argues for broader use of the cheap anti-diabetes drug and against the ...
Breaking News: Trump administration impacts continue to roil the life sciences sector Home » Macquarie University describes new 3CLpro inhibitors to treat SARS-CoV-2 infection ...
Stratus and Nimbus have similar symptoms to previous variants including a fever, cough and runny nose, but the Nimbus variant ...
InflaRx N.V. announced that the European Commission has granted exceptional marketing authorization for its drug GOHIBIC® (vilobelimab) to treat adult patients with SARS-CoV-2-induced acute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback